Skip to content

Cingulate Inc.: 10-Q filed 2022-11-14

What Cingulate Inc. reported in its quarterly report filed 2022-11-14 (fiscal Q3 2022): 36 published measures, 94 facts as tagged in accession 0001493152-22-031582.

This filing

Form
10-Q (quarterly report)
Filed
2022-11-14
Fiscal period
fiscal Q3 2022
Accession
0001493152-22-031582 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cingulate Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-09-3015,376,675USD
At 2021-12-3122,886,257USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-09-307,010,143USD
At 2021-12-312,042,715USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-09-308,366,532USD
At 2022-06-3012,184,874USD
At 2022-03-3116,018,601USD
At 2021-12-3120,843,542USD
At 2021-09-303,079,151USD
At 2021-06-301,899,380USD
At 2021-03-311,344,035USD
At 2020-12-311,292,270USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-09-309,795,570USD
At 2021-12-3116,492,745USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-4,027,247USD92
2022-01-01 to 2022-09-30-13,071,205USD273
2022-04-01 to 2022-06-30-4,040,447USD91
2022-01-01 to 2022-03-31-5,003,511USD90
2021-07-01 to 2021-09-30-15,290,048USD92
2021-01-01 to 2021-09-30-18,056,266USD273
2021-04-01 to 2021-06-30-1,432,295USD91
2021-01-01 to 2021-03-31-1,333,923USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-11,676,314USD273
2021-01-01 to 2021-09-30-5,810,009USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-01-01 to 2022-09-3010,400USD273
2021-01-01 to 2021-09-30104,729USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-09-304,988,771USD273
2021-01-01 to 2021-09-306,632,481USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-9,632USD273
2021-01-01 to 2021-09-30-104,729USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-09-30-64,803,469USD
At 2021-12-31-51,732,264USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-07-01 to 2022-09-3011,309,412shares92
2022-01-01 to 2022-09-3011,309,412shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-0.36USD/shares92
2022-01-01 to 2022-09-30-1.16USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-09-302,851,491USD
At 2021-12-313,145,378USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-01-01 to 2022-09-30594,360USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-3,968,362USD92
2022-01-01 to 2022-09-30-13,026,693USD273
2021-07-01 to 2021-09-30-15,279,489USD92
2021-01-01 to 2021-09-30-18,032,272USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-09-3011,834,412USD
At 2021-12-3118,882,279USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2022-07-01 to 2022-09-30104,839USD92

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-09-306,406,001USD
At 2021-12-311,176,678USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-09-30392,798USD
At 2021-12-31264,687USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-07-01 to 2022-09-302,123,114USD92
2022-01-01 to 2022-09-307,063,626USD273
2021-07-01 to 2021-09-305,791,407USD92
2021-01-01 to 2021-09-307,147,513USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-09-3011,309,412shares
At 2021-12-3111,309,412shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-09-3073,168,870USD
At 2021-12-3172,574,510USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2021-12-31165USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2022-09-30690,772USD
At 2021-12-31858,600USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2022-09-304,821,833USD
At 2021-12-314,811,433USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2022-09-301,970,342USD
At 2021-12-311,666,055USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2022-09-30670,651USD
At 2021-12-31601,300USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2022-09-301,991,493USD
At 2021-12-311,698,353USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2022-09-30327,287USD
At 2021-12-31510,676USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-4,027,247USD92
2022-01-01 to 2022-09-30-13,071,205USD273
2021-07-01 to 2021-09-30-15,290,048USD92
2021-01-01 to 2021-09-30-18,056,266USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-4,023,998USD92
2022-01-01 to 2022-09-30-13,071,371USD273
2021-07-01 to 2021-09-30-15,290,048USD92
2021-01-01 to 2021-09-30-18,056,266USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-301,845,248USD92
2022-01-01 to 2022-09-305,963,067USD273
2021-07-01 to 2021-09-309,488,082USD92
2021-01-01 to 2021-09-3010,884,759USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2022-07-01 to 2022-09-30101,429USD92
2022-01-01 to 2022-09-30304,287USD273
2021-07-01 to 2021-09-3077,797USD92
2021-01-01 to 2021-09-30528,809USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-58,885USD92
2022-01-01 to 2022-09-30-44,512USD273
2021-07-01 to 2021-09-30-10,559USD92
2021-01-01 to 2021-09-30-23,994USD273

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2022-01-01 to 2022-09-300USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2022-01-01 to 2022-09-3010,291USD273
2021-01-01 to 2021-09-308,090USD273

Inspect the source

Entity
Cingulate Inc. / CIK 0001862150
Captured
2026-09-21T17:31:56.019Z
SEC response SHA-256
59c430e5770a7e8cc03543e1d4bfa9a260f4983bc9e7b0469dac795e6803ef32

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001862150.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))